Public-registry site landscape for NCT04628481, a Recent Onset type1 Diabetes study sponsored by Dompé Farmaceutici S.p.A. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04628481 (registry record) |
| Sponsor | Dompé Farmaceutici S.p.A |
| Condition(s) | Recent Onset type1 Diabetes |
| Phase | PHASE2 |
| Listed sites | 57 |
| Site countries | United States, Belgium, Georgia, Germany, Israel, Italy, Serbia, Slovenia |
Eichor generates a preliminary site-risk snapshot for NCT04628481 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →